A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants

Inclusion Criteria: * 18 to 50 years of age * In good general health at Screening and/or before the first administration of IP * BMI \> 18.0 and \< 32.0 kg/m2 at Screening * Nonsmoker and must not have used any tobacco products within 2 months prior to screening * Females must not be pregnant or lactating, and females and males must use acceptable, highly effective double contraception during study and follow-up period * Person who can provide written informed consent prior to the commencement of all study procedures Exclusion Criteria: * Underlying physical or psychological medical condition to comply with the protocol or complete the study per protocol * Genetic disorder with severe and abnormal bilirubin metabolism * Blood or plasma donation or significant blood loss prior to the first administration of IP * Viral or bacterial infection prior to the first administration of IP * Poor venous access * Significant scarring or tattoos at the planned site of IP administration * History of severe allergic or anaphylactic reactions, or sensitivity to the IP or its constituents * History or active cardiovascular, respiratory, kidney, endocrine, blood, digestive, central nervous, urinary and/or musculoskeletal disease * History of malignancy prior to Screening * Abnormal ECG findings * History or presence of a condition associated with significant immunosuppression * History of life-threatening infection * Infections requiring parenteral antibiotics * Vaccination prior to the first administration of IP * Exposure to any significantly immune suppressing drug * Abnormal vital signs findings * Abnormal laboratory findings * Positive results for viral testing at Screening * Positive result at Screening and Day -1 for toxicology screening panel * History of substance abuse or dependency or history of recreational intravenous (IV) drug use * Excess of regular alcohol consumption * Use of any IP or investigational medical device within 30 days prior to Screening * Unable to adhere to the prohibited therapies * Unwilling to adhere to the dietary restrictions * Unwilling to refrain from strenuous exercise